MX2007011024A - Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin. - Google Patents
Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin.Info
- Publication number
- MX2007011024A MX2007011024A MX2007011024A MX2007011024A MX2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- hepcidin
- biomarkers
- biomarcators
- endometry
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Optics & Photonics (AREA)
- Organic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66209005P | 2005-03-11 | 2005-03-11 | |
| PCT/US2006/008578 WO2006099126A2 (en) | 2005-03-11 | 2006-03-10 | Biomarkers for ovarian cancer and endometrial cancer: hepcidin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007011024A true MX2007011024A (es) | 2009-11-23 |
Family
ID=36992262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007011024A MX2007011024A (es) | 2005-03-11 | 2006-03-10 | Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7510842B2 (OSRAM) |
| EP (1) | EP1869462B1 (OSRAM) |
| JP (1) | JP5069214B2 (OSRAM) |
| KR (1) | KR101310000B1 (OSRAM) |
| CN (1) | CN101189516A (OSRAM) |
| AU (1) | AU2006223374B2 (OSRAM) |
| CA (1) | CA2602088C (OSRAM) |
| IL (1) | IL185496A (OSRAM) |
| MX (1) | MX2007011024A (OSRAM) |
| NZ (1) | NZ560976A (OSRAM) |
| WO (1) | WO2006099126A2 (OSRAM) |
Families Citing this family (106)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
| US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
| GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
| US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
| EP2261672B1 (en) * | 2004-07-14 | 2014-09-03 | The Regents of The University of California | Biomarkers for early detection of ovarian cancer |
| US9488655B2 (en) * | 2004-07-14 | 2016-11-08 | The Regents Of The University Of California | Biomarkers for detection of early- and late-stage endometrial cancer |
| WO2012047930A2 (en) | 2010-10-04 | 2012-04-12 | The Regents Of The University Of California | Compositions and methods for treatment of gynecologic cancers |
| US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
| JP4801930B2 (ja) * | 2005-05-02 | 2011-10-26 | 株式会社Ｍｃｂｉ | 新規肝がんバイオマーカーおよび該バイオマーカーを用いた肝がんの検出方法 |
| CN101243319B (zh) * | 2005-06-22 | 2016-01-06 | 约翰·霍普金斯大学 | 卵巢癌的生物标记：ctap3-相关蛋白质 |
| US8465929B2 (en) * | 2005-06-24 | 2013-06-18 | Vermillion, Inc. | Biomarkers for ovarian cancer |
| WO2007022248A2 (en) * | 2005-08-16 | 2007-02-22 | Sloan Kettering Institute For Cancer Research | Methods of detection of cancer using peptide profiles |
| US7672916B2 (en) * | 2005-08-16 | 2010-03-02 | The Trustees Of Columbia University In The City Of New York | Methods, systems, and media for music classification |
| EP2363205A3 (en) | 2006-01-11 | 2014-06-04 | Raindance Technologies, Inc. | Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors |
| EP2530168B1 (en) | 2006-05-11 | 2015-09-16 | Raindance Technologies, Inc. | Microfluidic Devices |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| MX2009000685A (es) * | 2006-07-21 | 2009-01-30 | Amgen Inc | Metodo para detectar y/o cuantificar hepcidina en una muestra. |
| EP2077912B1 (en) | 2006-08-07 | 2019-03-27 | The President and Fellows of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
| WO2008060376A2 (en) * | 2006-10-04 | 2008-05-22 | The Johns Hopkins University | Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer |
| WO2008048508A2 (en) * | 2006-10-13 | 2008-04-24 | Vermillion, Inc. | Prognostic biomarkers in patients with ovarian cancer |
| WO2008047485A1 (en) * | 2006-10-17 | 2008-04-24 | Naohisa Tomosugi | Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator |
| WO2008049175A1 (en) * | 2006-10-24 | 2008-05-02 | Katholieke Universiteit Leuven | High discriminating power biomarker diagnosing |
| EP2087152B1 (en) * | 2006-10-27 | 2015-03-11 | Walfish, Paul | Endometrial biomarkers |
| AR065083A1 (es) * | 2007-02-02 | 2009-05-13 | Amgen Inc | Hepcidina, antagonistas de la hepcidina y metodos de uso |
| US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US8221984B2 (en) | 2007-03-27 | 2012-07-17 | Vermillion, Inc. | Biomarkers for ovarian cancer |
| WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| WO2008146903A1 (ja) | 2007-05-31 | 2008-12-04 | Naohisa Tomosugi | 活性型ヘプシジンを指標とした、急性虚血性疾患の診断方法 |
| CN101855553B (zh) | 2007-06-29 | 2014-06-11 | 韩国安国药品株式会社 | 卵巢癌的预测标记 |
| CA2694112A1 (en) * | 2007-07-20 | 2009-01-29 | The University Of Utah Research Foundation | Identification and quantification of biomarkers for evaluating the risk of preterm birth |
| US8039227B2 (en) * | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
| WO2009058331A2 (en) * | 2007-10-29 | 2009-05-07 | Vermilllion, Inc. | Biomarkers for the detection of early stage ovarian cancer |
| CL2008003190A1 (es) | 2007-11-02 | 2009-09-04 | Lilly Co Eli | Anticuerpo que se enlaza selectivamente a hepcidina-25 humana madura; polinucleotido codificante, vector y celula huesped que lo comprende; uso medico para tratar la anemia, incrementar nivel de hierro, conteo de rediculocito, celulas rojas, hemoglobina, o hematocritos; proceso de produccion; composicion farmaceutica. |
| US8728823B2 (en) * | 2007-11-23 | 2014-05-20 | British Columbia Cancer Agency Branch | Methods for detecting lung cancer and monitoring treatment response |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| WO2010009365A1 (en) | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
| PT2322221E (pt) | 2008-08-05 | 2014-09-19 | Toray Industries | Composição farmacêutica para tratamento e prevenção de cancro |
| US11137401B2 (en) | 2008-08-05 | 2021-10-05 | Toray Industries, Inc. | Method for detecting cancer using CAPRIN-1 as a marker |
| US8609817B2 (en) * | 2008-08-06 | 2013-12-17 | Eli Lilly And Company | Anti-hepcidin-25 selective antibodies and uses thereof |
| US20100068737A1 (en) * | 2008-09-16 | 2010-03-18 | University Of Tennessee Research Foundation | Enzyme-linked Immunosorbent Assay (ELISA) for Canine Hepcidin |
| US8528589B2 (en) | 2009-03-23 | 2013-09-10 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
| EP2273272A1 (en) | 2009-07-06 | 2011-01-12 | Stichting Katholieke Universiteit | Method for predicting the outcome of chemotherapy in ovarian cancer |
| US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
| CA2788716C (en) | 2010-02-04 | 2019-06-18 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| RU2603742C2 (ru) | 2010-02-04 | 2016-11-27 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| MX2012008991A (es) | 2010-02-04 | 2012-09-07 | Toray Industries | Medicamento para tratar y/o prevenir el cancer. |
| PL2532365T3 (pl) | 2010-02-04 | 2016-12-30 | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
| CN102834113B (zh) | 2010-02-04 | 2016-03-02 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| JP5845899B2 (ja) | 2010-02-04 | 2016-01-20 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| US9321818B2 (en) * | 2010-02-09 | 2016-04-26 | Academia Sinica | Dermcidin-derived peptides for lung cancer diagnostics |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| JP5934657B2 (ja) | 2010-02-12 | 2016-06-15 | レインダンス テクノロジーズ， インコーポレイテッド | デジタル検体分析 |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US20130236977A1 (en) * | 2010-05-24 | 2013-09-12 | Children's Medical Center Corporation | Compositions and methods for plasma peptide analysis |
| US20120046185A1 (en) * | 2010-08-06 | 2012-02-23 | Vermillion, Inc. | Panel of biomarkers for ovarian cancer |
| CN102375063A (zh) * | 2010-08-23 | 2012-03-14 | 湖州赛尔迪生物医药科技有限公司 | 一种常见蛋白质的免疫质谱试剂盒及制备方法 |
| WO2012045012A2 (en) | 2010-09-30 | 2012-04-05 | Raindance Technologies, Inc. | Sandwich assays in droplets |
| AU2011316844A1 (en) * | 2010-10-22 | 2013-06-06 | Vermillion, Inc. | Prognostic biomarkers in patients with ovarian cancer |
| EP3859011A1 (en) | 2011-02-11 | 2021-08-04 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| EP2675819B1 (en) | 2011-02-18 | 2020-04-08 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| DE202012013668U1 (de) | 2011-06-02 | 2019-04-18 | Raindance Technologies, Inc. | Enzymquantifizierung |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| CA2844030C (en) | 2011-08-04 | 2019-09-03 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| TR201808595T4 (tr) | 2011-08-04 | 2018-07-23 | Toray Industries | Kanser hastalıklarının tedavisi ve/veya profilaksisi için farmasötik bileşim. |
| RU2611197C2 (ru) | 2011-08-04 | 2017-02-21 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли |
| EP2741085B1 (en) | 2011-08-04 | 2017-04-05 | Toray Industries, Inc. | Method for detecting pancreatic cancer |
| WO2013018886A1 (ja) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | 膵臓癌の治療及び／又は予防用医薬組成物 |
| PT2740796T (pt) | 2011-08-04 | 2017-07-26 | Toray Industries | Composição farmacêutica para o tratamento e/ou profilaxia de cancro |
| KR101968498B1 (ko) | 2011-08-04 | 2019-04-12 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| JP6078067B2 (ja) | 2011-08-29 | 2017-02-08 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 炎症誘発性状態の治療および予防のためのｈｄｌ関連分子の使用 |
| WO2013120089A1 (en) | 2012-02-10 | 2013-08-15 | Raindance Technologies, Inc. | Molecular diagnostic screening assay |
| CN104114583B (zh) | 2012-02-21 | 2019-11-19 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| KR102005308B1 (ko) | 2012-02-21 | 2019-07-30 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| EP2818482B1 (en) | 2012-02-21 | 2019-05-22 | Toray Industries, Inc. | Pharmaceutical composition for treatment of cancer |
| IN2014KN01715A (OSRAM) | 2012-02-21 | 2015-10-23 | Toray Industries | |
| PL2832365T3 (pl) | 2012-03-30 | 2018-04-30 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi wątroby |
| EP2832366B1 (en) | 2012-03-30 | 2017-11-08 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of gallbladder cancer |
| EP2844768B1 (en) | 2012-04-30 | 2019-03-13 | Raindance Technologies, Inc. | Digital analyte analysis |
| JP6244911B2 (ja) | 2012-07-19 | 2017-12-13 | 東レ株式会社 | 癌の検出方法 |
| ES2769831T3 (es) | 2012-07-19 | 2020-06-29 | Toray Industries | Método para detectar cáncer |
| EP2968503B1 (en) * | 2013-03-15 | 2018-08-15 | Intrinsic LifeSciences LLC | Anti-hepcidin antibodies and uses thereof |
| EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| HUE042081T2 (hu) | 2013-08-09 | 2019-06-28 | Toray Industries | Gyógyászati készítmény rák kezelésére és/vagy megelõzésére |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
| TWI598577B (zh) * | 2014-03-28 | 2017-09-11 | 梅托珍尼克斯股份有限公司 | Method for obtaining data for determining possibility of carcinogenesis of endometriotic ovarian cysts, and diagnostic apparatus thereof |
| EP2955517A1 (de) * | 2014-06-10 | 2015-12-16 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur Stabilisierung von Körperflüssigkeitsproben durch die Zugabe von Detergenz |
| WO2016049036A1 (en) | 2014-09-22 | 2016-03-31 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
| GB2530521B (en) * | 2014-09-24 | 2020-06-10 | Map Ip Holding Ltd | Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin |
| JP2017535750A (ja) * | 2014-09-24 | 2017-11-30 | マップ アイピー ホールディング リミテッド | 妊娠の予後を提供する方法 |
| ES2955883T3 (es) | 2015-06-19 | 2023-12-07 | Sera Prognostics Inc | Pares de biomarcadores para la predicción del parto prematuro |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| CN106872593B (zh) * | 2017-02-04 | 2021-05-04 | 江西省妇幼保健院 | 溶血磷脂酸作为标志物在检测子宫内膜异位症中的应用 |
| AU2018317902B2 (en) | 2017-08-18 | 2025-02-20 | Sera Prognostics, Inc. | Pregnancy clock proteins for predicting due date and time to birth |
| US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
| AU2018324195B2 (en) | 2017-09-01 | 2024-12-12 | Venn Biosciences Corporation | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring |
| CN108152430A (zh) * | 2017-12-21 | 2018-06-12 | 上海中科新生命生物科技有限公司 | 基于prm检测的卵巢癌标志物检测试剂盒及检测方法 |
| EP4107525A4 (en) * | 2020-02-19 | 2024-08-14 | Aspira Women's Health Inc. | Compositions for endometriosis assessment having improved specificity |
| US20230280349A1 (en) * | 2022-03-01 | 2023-09-07 | The University Of Chicago | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor |
| AU2023406952A1 (en) * | 2022-12-02 | 2025-06-19 | Aspira Women's Health Inc. | Compositions for endometriosis assessment having improved specificity |
| WO2024192014A1 (en) * | 2023-03-12 | 2024-09-19 | Novelna Inc. | Endometrial cancer detection proteins and methods of use thereof |
| CN119757576A (zh) * | 2024-12-26 | 2025-04-04 | 哈尔滨脉图精准技术有限公司 | 一种用于区分健康与宫颈癌的代谢标志物组合及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6283761B1 (en) | 1992-09-08 | 2001-09-04 | Raymond Anthony Joao | Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information |
| US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| AU2003235749A1 (en) * | 2002-01-07 | 2003-07-24 | John Hopkins University | Biomarkers for detecting ovarian cancer |
| NZ562192A (en) * | 2002-08-06 | 2009-07-31 | Ciphergen Biosystems Inc | Use of biomarkers for detecting ovarian cancer |
| AU2003295644A1 (en) * | 2002-11-19 | 2004-07-22 | Drg International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| WO2004105573A2 (en) * | 2003-05-21 | 2004-12-09 | The Wistar Institute Of Anatomy And Biology | Method of diagnosis of cancer based on gene expression profiles in cells |
| CA2528669A1 (en) * | 2003-06-09 | 2005-01-20 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US7670792B2 (en) * | 2004-07-14 | 2010-03-02 | The Regents Of The University Of California | Biomarkers for early detection of ovarian cancer |
| US8465929B2 (en) * | 2005-06-24 | 2013-06-18 | Vermillion, Inc. | Biomarkers for ovarian cancer |
-
2006
- 2006-03-10 JP JP2008500963A patent/JP5069214B2/ja not_active Expired - Lifetime
- 2006-03-10 KR KR1020077023307A patent/KR101310000B1/ko not_active Expired - Lifetime
- 2006-03-10 CN CNA2006800078086A patent/CN101189516A/zh active Pending
- 2006-03-10 MX MX2007011024A patent/MX2007011024A/es active IP Right Grant
- 2006-03-10 EP EP06737729.1A patent/EP1869462B1/en not_active Expired - Lifetime
- 2006-03-10 NZ NZ560976A patent/NZ560976A/en not_active IP Right Cessation
- 2006-03-10 WO PCT/US2006/008578 patent/WO2006099126A2/en not_active Ceased
- 2006-03-10 US US11/373,833 patent/US7510842B2/en not_active Expired - Lifetime
- 2006-03-10 CA CA2602088A patent/CA2602088C/en not_active Expired - Lifetime
- 2006-03-10 AU AU2006223374A patent/AU2006223374B2/en not_active Expired
-
2007
- 2007-08-23 IL IL185496A patent/IL185496A/en active IP Right Grant
-
2009
- 2009-03-09 US US12/381,218 patent/US20100068724A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101189516A (zh) | 2008-05-28 |
| AU2006223374A1 (en) | 2006-09-21 |
| IL185496A (en) | 2012-07-31 |
| KR101310000B1 (ko) | 2013-09-25 |
| JP2008533471A (ja) | 2008-08-21 |
| EP1869462B1 (en) | 2013-05-08 |
| WO2006099126A2 (en) | 2006-09-21 |
| JP5069214B2 (ja) | 2012-11-07 |
| CA2602088C (en) | 2021-07-27 |
| CA2602088A1 (en) | 2006-09-21 |
| IL185496A0 (en) | 2008-01-06 |
| KR20080044801A (ko) | 2008-05-21 |
| US20100068724A1 (en) | 2010-03-18 |
| EP1869462A4 (en) | 2009-01-14 |
| EP1869462A2 (en) | 2007-12-26 |
| US7510842B2 (en) | 2009-03-31 |
| NZ560976A (en) | 2011-06-30 |
| US20070054329A1 (en) | 2007-03-08 |
| AU2006223374B2 (en) | 2011-07-21 |
| WO2006099126A3 (en) | 2006-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006099126A3 (en) | Biomarkers for ovarian cancer and endometrial cancer: hepcidin | |
| IL251791B (en) | Biomarker for ovarian cancer: ctap3-related proteins | |
| DE602006017365D1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
| WO2007002535A8 (en) | Biomarkers for ovarian cancer | |
| IL252832A0 (en) | Use of biomarkers for detecting ovarian cancer | |
| WO2006089125A3 (en) | Methods of detecting ovarian cancer | |
| WO2006116127A3 (en) | Compositions for use in identification of bacteria | |
| WO2007118222A3 (en) | Compositions for the use in identification of fungi | |
| DE602004019812D1 (de) | Marker für neuromyelitis optica | |
| WO2007035766A3 (en) | Biomarker for prostate cancer | |
| ATE490465T1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
| BR112013000869A2 (pt) | método para diagnóstico de câncer de próstata (pca) com uma sensibilidade desejada em um sujeito; método para monitorar a progressão do câncer de próstata (pca) em um sujeito; método para avaliar se um sujeito tem que ser submetido a uma biópsia de próstata; kit compreendendo um primeiro componente e, opcionalmente, um segundo componente e uso de um kit | |
| DE602006020544D1 (de) | Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs | |
| WO2008048508A3 (en) | Prognostic biomarkers in patients with ovarian cancer | |
| BRPI0607323A2 (pt) | composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo | |
| WO2007149809A3 (en) | Tacrolimus standard and methods of using same | |
| DE602005016800D1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| WO2005044794A3 (en) | Immunohistochemical methods | |
| WO2007008647A3 (en) | Diagnosing and grading gliomas using a proteomics approach | |
| GT200600314A (es) | Complejos metalicos con contenido de perfluroalquilo, procedimientos para su preparacion, asi como su uso. | |
| WO2006128082A3 (en) | Biomarkers for breast cancer | |
| WO2003076896A3 (en) | Use of biomarkers to detect breast cancer | |
| WO2006113289A3 (en) | Saposin d and fam3c are biomarkers for alzheimer's disease | |
| SG127861A1 (en) | in situ biomarker identification | |
| ATE467128T1 (de) | Kolloidale metallkonjugate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |